![Mette Husbyn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mette Husbyn
Technik-/Wissenschafts-/F&E-Leiter bei
LYTIX BIOPHARMA ASA
Profil
Mette Husbyn currently works at Lytix Biopharma AS, as Chief Technical Officer from 2025.
Dr. Husbyn also formerly worked at Lytix Biopharma AS, as Head-CMC from 2012 to 2017 and Nykode Therapeutics ASA, as Chief Technical Officer & Head-CMC from 2017 to 2025.
Dr. Husbyn received her doctorate degree in 2003 from the University of Oslo.
Aktive Positionen von Mette Husbyn
| Unternehmen | Position | Beginn |
|---|---|---|
| LYTIX BIOPHARMA ASA | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2025 |
Ehemalige bekannte Positionen von Mette Husbyn
| Unternehmen | Position | Ende |
|---|---|---|
| NYKODE THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2025 |
| LYTIX BIOPHARMA ASA | Corporate Officer/Principal | 01.01.2017 |
Ausbildung von Mette Husbyn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lytix Biopharma AS
 Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
Nykode Therapeutics ASA
 Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
